Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-07-19 Sale | 2023-07-21 4:02 pm | ViewRay Inc. | VRAY | Prange Karen Director | 129,466 | $0.06803 | $8,808 | 8,799 (Direct) | View |
| 2023-06-08 Sale | 2023-06-12 08:59 am | AtriCure Inc. | ATRC | Prange Karen Director | 713 | $47.89 | $34,146 | 16,140 (Direct) | View |
| 2022-05-10 Purchase | 2022-05-12 06:05 am | ViewRay Inc. | VRAY | Prange Karen Director | 37,600 | $2.6596 | $100,002 | 83,754 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-23 Option Award | 2024-05-28 6:55 pm | N/A N/A | NEVRO CORP | NVRO | Prange Karen Director | 19,169 | $0 | 33,948 (Direct) | View |
| 2024-05-13 Option Award | 2024-05-14 5:04 pm | N/A N/A | AtriCure Inc. | ATRC | Prange Karen Director | 7,788 | $0 | 23,928 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 6:08 pm | N/A N/A | Embecta Corp. | EMBC | Prange Karen Director | 11,455 | $0 | 24,898 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 5:15 pm | N/A N/A | NEVRO CORP | NVRO | Prange Karen Director | 6,754 | $0 | 14,779 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-26 4:25 pm | N/A N/A | AtriCure Inc. | ATRC | Prange Karen Director | 3,186 | $0 | 16,853 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-10 4:09 pm | N/A N/A | Embecta Corp. | EMBC | Prange Karen Director | 6,979 | $0 | 13,069 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 4:09 pm | N/A N/A | ViewRay Inc. | VRAY | Prange Karen Director | 54,511 | $0 | 138,265 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 8:59 pm | N/A N/A | NEVRO CORP | NVRO | Prange Karen Director | 4,155 | $0 | 8,025 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-27 09:03 am | N/A N/A | AtriCure Inc. | ATRC | Prange Karen Director | 3,564 | $0 | 13,667 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 5:38 pm | N/A N/A | Embecta Corp. | EMBC | Prange Karen Director | 6,024 | $0 | 6,024 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-06 4:32 pm | N/A N/A | ViewRay Inc. | VRAY | Prange Karen Director | 26,395 | $0 | 46,154 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-16 4:25 pm | N/A N/A | ViewRay Inc. | VRAY | Prange Karen Director | 19,759 | $0 | 19,759 (Direct) | View |
| 2021-06-02 Disposition | 2021-06-02 5:27 pm | N/A N/A | CANTEL MEDICAL CORP | CMD | Prange Karen Director | 1,935 | $80.59 | 0 (Direct) | View |
| 2021-05-25 Option Award | 2021-05-26 9:01 pm | N/A N/A | NEVRO CORP | NVRO | Prange Karen Director | 1,167 | $0 | 3,870 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 4:52 pm | N/A N/A | AtriCure Inc. | ATRC | Prange Karen Director | 1,749 | $0 | 10,103 (Direct) | View |
| 2020-07-31 Option Award | 2020-07-31 5:53 pm | N/A N/A | CANTEL MEDICAL CORP | CMD | Prange Karen Director | 1,935 | $0 | 1,935 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 08:28 am | N/A N/A | AtriCure Inc. | ATRC | Prange Karen Director | 2,452 | $0 | 8,354 (Direct) | View |
| 2019-12-17 Option Award | 2019-12-18 4:31 pm | N/A N/A | NEVRO CORP | NVRO | Prange Karen Director | 2,703 | $0 | 2,703 (Direct) | View |
| 2019-12-04 Option Award | 2019-12-05 4:24 pm | N/A N/A | AtriCure Inc. | ATRC | Prange Karen Director | 5,902 | $0 | 5,902 (Direct) | View |
Ownership | 2019-12-04 08:13 am | N/A N/A | AtriCure Inc. | ATRC | Prange Karen Director | 0 | $0 | 0 (Direct) | View |